Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1091-1100 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|September 23, 2016
Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in miceChenguang Zhou, Sophie Lehar, Johnny Gutierrez, et al.
Mabs|May 21, 2019
Connecting the sequence dots: shedding light on the genesis of antibodies reported to be designed in silicoMaximiliano Vásquez, Eric Krauland, Laura Walker, et al.
Mabs|March 29, 2018
A unique allosteric insulin receptor monoclonal antibody that prevents hypoglycemia in the SUR-1<sup>-/-</sup> mouse model of KATP hyperinsulinismPuja Patel, Lawrenshey Charles, John Corbin, et al.
Mabs|March 30, 2018
Corrigendum
Mabs|December 19, 2019
Antibodies to watch in 2020Hélène Kaplon, Mrinalini Muralidharan, Zita Schneider, et al.
Mabs|January 12, 2020
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosisSarah Low, Haixia Wu, Kavita Jerath, et al.
Mabs|January 14, 2020
Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding siteKarl J M Hanf, Joseph W Arndt, YuTing Liu, et al.
Mabs|December 20, 2019
Harnessing MerTK agonism for targeted therapeuticsVivekananda Kedage, Diego Ellerman, Yongmei Chen, et al.
Mabs|May 31, 2022
Enzymatic glycan remodeling-metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineeringMarloes A Wijdeven, Remon van Geel, Jorin H Hoogenboom, et al.
Mabs|December 6, 2018
Antibodies to watch in 2019Hélène Kaplon, Janice M Reichert
Pageof 184

Showing results (1091-1100 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|September 23, 2016
Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in miceChenguang Zhou, Sophie Lehar, Johnny Gutierrez, et al.
Mabs|May 21, 2019
Connecting the sequence dots: shedding light on the genesis of antibodies reported to be designed in silicoMaximiliano Vásquez, Eric Krauland, Laura Walker, et al.
Mabs|March 29, 2018
A unique allosteric insulin receptor monoclonal antibody that prevents hypoglycemia in the SUR-1<sup>-/-</sup> mouse model of KATP hyperinsulinismPuja Patel, Lawrenshey Charles, John Corbin, et al.
Mabs|March 30, 2018
Corrigendum
Mabs|December 19, 2019
Antibodies to watch in 2020Hélène Kaplon, Mrinalini Muralidharan, Zita Schneider, et al.
Mabs|January 12, 2020
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosisSarah Low, Haixia Wu, Kavita Jerath, et al.
Mabs|January 14, 2020
Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding siteKarl J M Hanf, Joseph W Arndt, YuTing Liu, et al.
Mabs|December 20, 2019
Harnessing MerTK agonism for targeted therapeuticsVivekananda Kedage, Diego Ellerman, Yongmei Chen, et al.
Mabs|May 31, 2022
Enzymatic glycan remodeling-metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineeringMarloes A Wijdeven, Remon van Geel, Jorin H Hoogenboom, et al.
Mabs|December 6, 2018
Antibodies to watch in 2019Hélène Kaplon, Janice M Reichert
Pageof 184